Rare diseases
Investigational molecules
Locations
A study of LTP001 in combination with standard treatment for adults with pulmonary arterial hypertension
FranceStudy of intrathecal S230815 to evaluate safety and effectiveness in children with KCNT1-related Developmental and Epileptic Encephalopathy
FranceStudy of bedaquiline, pretomanid, linezolid and moxifloxacin combination treatment for patients with multidrug-resistant tuberculosis in France
FranceStudy comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy
FranceStudy of etentamig and iberdomide treatment for patients with relapsed or refractory multiple myeloma
FranceStudy of belumosudil in children aged 1 to 18 years with moderate to severe chronic graft versus host disease requiring systemic treatment
FranceStudy of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
FranceStudy of drug combination therapy in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma using odronextamab, loncastuximab tesirine and rituximab
FranceStudy of tarlatamab and temozolomide combination treatment in adolescents and adults with high grade brain tumors
FranceStudy comparing tadalafil with ambrisentan versus tadalafil alone in newly diagnosed patients with pulmonary arterial hypertension who have cardiovascular conditions
FranceStudy comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment
FranceStudy of 177Lu-FAP-2286 alone and with drug combinations for patients with advanced solid tumors including non-small cell lung cancer, breast cancer, and pancreatic cancer
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
